ENDPOINTS

AstraZeneca, CSPC ink AI drug development deal for $110M upfront 

AstraZeneca is further tightening its relationship with China as it announced a new research partnership with CSPC Pharmaceuticals on Friday. CSPC will receive $110 million upfront for the partners to develop preclinical oral candidates for ...

Jun 13, 2025 - 13:30
 0
AstraZeneca, CSPC ink AI drug development deal for $110M upfront 
AstraZeneca is further tightening its relationship with China as it announced a new research partnership with CSPC Pharmaceuticals on Friday. CSPC will receive $110 million upfront for the partners to develop preclinical oral candidates for ...
Read More

Tags:

Previous Article

Tectonic Plates Can ‘Infect’ One Another with Earth-Shaking Subduction Zones

Next Article

A high-resolution spectrometer that fits into smartphones

Related Posts

#ASCO25: Kura spells out pivotal AML trial win as it gears up to compete with Syndax

#ASCO25: Kura spells out pivotal AML trial win as it ge...

May 23, 2025  0

TCG's R&D venture team makes a T cell engager deal with Shanghai biotech

TCG's R&D venture team makes a T cell engager deal with...

May 27, 2025  0

Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M

Vera redraws the terms of up to $500M credit facility; ...

Jun 3, 2025  0